CORPORATE GOVERNANCE REPORT Rex International Holding Limited 151 1207(19) Dealings in Securities The Company and its subsidiaries have adopted an internal policy which prohibits the Directors and officers (including employees) from dealing in the securities of the Company while in possession of price-sensitive information. The Company, its Directors and officers (including employees) of the Company and its subsidiaries are also discouraged from dealing in the Company’s securities on short-term considerations and are prohibited from dealing in the Company’s securities during the period beginning one month before the announcement of the Company’s half-year and full-year financial statements, and ending on the date of the announcement of the relevant results. 1207(20) Use of Proceeds Raised from Placement Exercises 2026 Placement The Company completed the placement of 13,187,000 treasury shares on 5 February 2026 and subsequently completed the allotment and issuance of 40,082,930 new ordinary shares on 13 March 2026 (the “2026 Placement”). The 2026 Placement raised total net proceeds of S$7.32 million (after deducting actual placement expenses of S$0.30 million). The details of the utilisation of the net proceeds from the 2026 Placement (which was made in accordance with the stated use) as at the date of this report is as follows: Use of Proceeds Amount Allocated Amount utilised Balance S$’000 S$’000 S$’000 General corporate purposes 7,321 (498)1 6,823 Total 7,321 (498) 6,823 (1) S$0.50 million was used for Singapore’s office staff cost and operational expenses (S$0.23 million), consultancy fees (S$0.02 million) and professional fees (S$0.25 million) in January - February 2026. 2013 Placement The Company had on 6 November 2013, completed a placement of 70 million new ordinary shares at an issue price of S$0.755 per share (the “2013 Placement”), raising net proceeds of S$50.87 million (after deducting placement expenses of S$1.98 million). As at the date of this report, the Company had utilised all the 2013 Placement proceeds except for the amount allocated to the share buyback mandate of S$5.96 million. The Company utilised S$0.99 million in relation to the share buyback exercise in the financial year ended 2019. No share buybacks were conducted from FY2020 to FY2025. The ending balance of the amount allocated to the share buyback mandate as at 31 December 2025 and the date of this report was S$4.97 million. 720(6) Additional Information on Directors Seeking Re-election Pursuant to Listing Rule 720(6), the additional information as set out in Appendix 7.4.1 of the Listing Rules relating to the retiring Directors who are submitting themselves for re-election, is disclosed below and to be read in conjunction with their respective biographies under the section entitled “Board of Directors” of this Annual Report:
RkJQdWJsaXNoZXIy NTM2MDQ5